Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation.

Hurlburt, Nicholas K; Wan, Yu-Hsin; Stuart, Andrew B; Feng, Junli; McGuire, Andrew T; Stamatatos, Leonidas; Pancera, Marie

Hurlburt, Nicholas K; Wan, Yu-Hsin; Stuart, Andrew B; Feng, Junli; McGuire, Andrew T; Stamatatos, Leonidas; Pancera, Marie.

Afiliación

Hurlburt NK; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Wan YH; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Stuart AB; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Feng J; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
McGuire AT; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.
Stamatatos L; University of Washington, Department of Global Health, Seattle, WA, USA.
Pancera M; Fred Hutchinson Cancer Research Center, Vaccines and Infectious Diseases Division, Seattle, WA, USA.

bioRxiv ; 2020 Jun 12.

Article en En | MEDLINE | ID: mdl-32577631

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google